Western blot results showed that the protein expression levels of β-catenin, cyclin D1, MMP-7, and c-Myc prominently decreased after MA treatment in a dose-dependent manner (Figures 4A,B) which suggested the contribution of MA against the proliferation of cervical cancer cells through downregulating the expression level of the critical protein, i.e., β-catenin, cyclin D1, MMP-7, and c-Myc of Wnt/β-catenin signaling cascade. The gene discussed is CCND1; the disease is cervical carcinoma.